BlackRock Investment Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

BlackRock Investment Management’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1K	Hold	41	–	–	﹤0.01%	3920
2016 Q3	$2K	Hold	41	–	–	﹤0.01%	3897
2016 Q2	$2K	Buy	+41	New	+$1.75K	﹤0.01%	3999

Other funds holding FSTX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

WSFS

Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return

Verity & Verity Beaufort, South Carolina $1.34B AUM 18.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

BlackRock Investment Management's FSTX Position: Q4 2016 in Review

BlackRock Investment Management held its F-star Therapeutics, Inc. Common Stock (FSTX) position steady in Q4 2016 at 41 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #3920.

BlackRock Investment Management first reported a position in FSTX in Q2 2016 and has held it in 3 quarters since. The position peaked at $2K in Q3 2016. 11 funds tracked by Wall St. Rank hold FSTX as of Q4 2016.

BlackRock Investment Management held 41 shares of F-star Therapeutics, Inc. Common Stock worth $1K as of Q4 2016.
BlackRock Investment Management left its F-star Therapeutics, Inc. Common Stock share count unchanged in Q4 2016.
F-star Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3920 holding.
BlackRock Investment Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2016 and has held it in 3 quarters since.
BlackRock Investment Management's F-star Therapeutics, Inc. Common Stock position peaked at $2K in Q3 2016.
11 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.